Skip to main content
رجوع
Watch Compare

Evommune, Inc.

جودة البيانات: 100%
EVMN
NYSE Manufacturing Chemicals
KWD 28.30
▲ KWD 1.17 (4.31%)
القيمة السوقية: 1.02 B
السعر
KWD 28.30
القيمة السوقية
1.02 B
نطاق اليوم
KWD 27.11 — KWD 28.72
نطاق 52 أسبوعًا
KWD 13.89 — KWD 33.20
حجم التداول
139,211
فتح KWD 27.11
متوسط 50 يوم / 200 يوم
KWD 23.81
18.85% above
متوسط 50 يوم / 200 يوم
KWD 21.21
33.42% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -76.68 M
Capital efficient — spends only 1.81% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-33.50%
أعلى من متوسط القطاع (-53.41%)
ROIC-30.93%
Net Margin-529.77%
Op. Margin-623.62%

الأمان

Debt / Equity
N/A
Current Ratio7.87
Interest CoverageN/A

التقييم

PE (TTM)
-14.80
أقل من متوسط القطاع (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -14.8 -1.5
P/B — 1.6
ROE % -33.5 -53.4
Net Margin % -529.8 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 13.00 M Net Income (TTM) -68.87 M
ROE -33.50% ROA -30.62%
Gross Margin N/A Operating Margin -623.62%
Net Margin -529.77% Free Cash Flow (TTM) -76.68 M
ROIC -30.93% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7.87
Interest Coverage N/A Asset Turnover 0.06
Working Capital 71.53 M Tangible Book Value -183.14 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -14.80 Forward P/E N/A
P/B Ratio N/A P/S Ratio 78.41
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7.52%
Market Cap 1.02 B Enterprise Value 992.51 M
Per Share
EPS (Diluted TTM) -11.22 Revenue / Share 0.36
FCF / Share -2.13 OCF / Share -2.12
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.81% FCF Conversion 111.33%
SBC-Adj. FCF -82.53 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 13.00 M
Net Income -68.87 M
EPS (Diluted) -11.22
Gross Profit —
Operating Income -81.07 M
EBITDA —
R&D Expenses 74.04 M
SG&A Expenses —
D&A 600,000.0
Interest Expense —
Income Tax 0.0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 224.95 M
Total Liabilities 19.38 M
Shareholders' Equity 205.57 M
Total Debt —
Cash & Equivalents 44.06 M
Current Assets 153.48 M
Current Liabilities 17.91 M